6 resultados
FIELD OF THE INVENTION
The present invention relates to the field of treatments for inflammatory and cardiovascular diseases, and chemotherapeutic agents. More particularly, the present invention relates to novel 1,4-bis-(amino-hydroxylalkylamino)-anthraquinones for inhibiting the enzyme protein
FIELD OF THE INVENTION
The present invention relates to the field of treatments for inflammatory and cardiovascular diseases, and chemotherapeutic agents. More particularly, the present invention relates to novel asymmetric 1,4-bis-(amino-hydroxylalkylamino)-anthraquinones for inhibiting the enzyme
FIELD OF THE INVENTION
The present invention relates generally to compositions for use in treating inflammatory bowel diseases, and more specifically to compositions comprising diacerein for use in treating ulcerative colitis, Crohn's disease, acute intestinal colitis, inflamed anus or
STATEMENT OF RELATED APPLICATIONS
This application is the U.S. National Phase under Chapter II of the Patent Cooperation Treaty (PCT) of PCT International Application No. PCT/BR2008/000028 having an International Filing Date of 30 Jan. 2008, which claims priority on Brazilian Patent Application No.
FIELD OF INVENTION
The present invention relates to a method of using Rhein for treating chronic pancreatitis induced fibrosis of pancreas in a subject in needs thereof. More particularly, the present invention relates to the method of using an anthraquinone derivative, namely
FIELD OF THE INVENTION
This disclosure relates to cancer drugs in general and, more specifically, to anti-tumor compounds derived from 1,4,5,8-tetrachloroanthraquinone
BACKGROUND
It is known that certain 1,4 bishydroxyethylaminoethylamino and 1,4,aminoethylaminoanthraquinones have anticancer